[1] Shah MV, Hook CC, Call TG, et al. A population-based study of large granular lymphocyte leukemia[J]. Blood Cancer J, 2016 ,6(8):e455. DOI: 10.1038/bcj.2016.59.
[2] Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the world health organization classification of lymphoid neoplasms[J]. Blood, 2016 ,127(20):2375-2390. DOI: 10.1182/blood-2016-01-643569.
[3] Dearden C. Large granular lymphocytic leukaemia pathogenesis and management[J]. Br J Haematol, 2011 ,152(3):273-283. DOI: 10.1111/j.1365-2141.2010.08494.x..
[4] 刘泽法,周瑶,陈宝安,等. 大颗粒淋巴细胞白血病合并纯红细胞再生障碍性贫血三例并文献复习[J]. 白血病·淋巴瘤,2019(5):297-299. DOI:10.3760/cma.j.issn.1009ˉ9921.2019.05.010.
[5] Kuusanmäki H, Dufva O, Parri E, et al. Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling[J]. Oncotarget, 2017 ,8(57):97516-97527. DOI: 10.18632/oncotarget.22178.
[6] Oye M, Alkhasawneh A, Quan JR. Gamma-delta large granular lymphocytic leukemia: a diagnostic dilemma[J]. Cureus, 2022 ,14(4):e24124. DOI: 10.7759/cureus.24124.
[7] Moignet A, Lamy T. Latest advances in the diagnosis and treatment of large granular lymphocytic leukemia[J]. Am Soc Clin Oncol Educ Book, 2018 ,38:616-625. DOI: 10.1200/EDBK_200689.
[8] Steinway SN, LeBlanc F, Loughran TP. The pathogenesis and treatment of large granular lymphocyte leukemia[J]. Blood Rev, 2014 ,28(3):87-94. DOI: 10.1016/j.blre.2014.02.001.
[9] Hirsh MI, Junger WG. Roles of heat shock proteins and gamma delta T cells in inflammation[J]. Am J Respir Cell Mol Biol, 2008 ,39(5):509-513. DOI: 10.1165/rcmb.2008-0090TR.
[10] Chen H, You H, Wang L, et al. Chaperonin-containing T-complex protein 1 subunit ζ serves as an autoantigen recognized by human Vδ2 γδ T cells in autoimmune diseases[J]. J Biol Chem, 2016 ,291(38):19985-19993. DOI: 10.1074/jbc.M115.700070.
[11] Wu M, Yang J, Li X, et al. The role of γδ T cells in systemic lupus erythematosus[J]. J Immunol Res, 2016,2016:2932531. DOI: 10.1155/2016/2932531.
[12] Qiu ZY, Qin R, Tian GY, et al. Pathophysiologic mechanisms and management of large granular lymphocytic leukemia associated pure red cell aplasia[J]. Onco Targets Ther, 2019 ,12:8229-8240. DOI: 10.2147/OTT.S222378.
[13] Chen YH, Peterson L. Differential diagnosis of CD4-/CD8- γδ T-cell large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma[J]. Am J Clin Pathol, 2012,137(3):496-497. DOI: 10.1309/AJCPCOPRE1HGD0FC.
[14] 周康,王慧君,张莉,等. T细胞大颗粒淋巴细胞白血病合并纯红细胞再生障碍的临床特征[J]. 中华血液学杂志, 2008, 29(5):312-315. DOI:10.3321/j.issn: 0253-2727.2008.05.007.
[15] Ishida F, Matsuda K, Sekiguchi N, et al. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia[J]. Cancer Sci, 2014, 105(3):342-346. DOI:10.1111/cas.12341.
[16] 朱阳敏, 高清妍, 胡靖, 等. γδT细胞大颗粒淋巴细胞白血病17例临床及实验室表现[J]. 中华血液学杂志,2020,41 (2):112-116. DOI: 10.3760/cma.j.issn. 0253-2727.2020.02.005.
[17] Gowda L, Foss F. Hepatosplenic T-Cell Lymphomas[J].Cancer Treat Res, 2019, 176:185-193. DOI:10.1007/978-3-319-99716-2_9.
[18] Nagel S, Pommerenke C, MacLeod RAF , et al. Deregulated expression of NKL homeobox genes in T-cell lymphomas[J]. Oncotarget, 2019, 10(35):3227-3247. DOI:10.18632/oncotarget.26929.
[19] Braunstein Z, Mishra A, Staub A, et al. Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response[J]. Br J Haematol, 2021, 192(3):484-493. DOI:10.1111/bjh.16808.
[20] Sanikommu SR, Clemente MJ, Chomczynski P, et al. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)[J]. Leuk Lymphoma, 2018, 59(2):416-422. DOI:10.1080/10428194.2017.1339880.
[21] Hu Q, Li YF, Zhang Y, et al. Case Report: first report of T-Cell large granular lymphocytic leukemia with NPL-DHX9 gene fusion successfully treated with cladribine: clinical experience and literature review[J]. Front Oncol, 2022, 12:824393. DOI:10.3389/fonc.2022.824393.
[22] Bai F, Villagra AV, Zou JX, et al. Tipifarnib-mediated suppression of T-bet-dependent signaling pathways[J]. Cancer Immunol Immunother, 2012, 61(4):523-533. DOI:10.1007/s00262-011-1109-0.
[23] Alonso-Alonso R, Mondéjar R, Martínez N, et al. Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma[J]. Sci Rep, 2020, 10(1):6721. DOI:10.1038/s41598-020-63434-5.
[24] Dumitriu B, Ito S, Feng XM, et al. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study[J]. Lancet Haematol, 2016, 3(1):e22-e29. DOI:10.1016/S2352-3026(15)00227-6.
|